Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William H. Rastetter is active.

Publication


Featured researches published by William H. Rastetter.


Toxicology and Applied Pharmacology | 1986

Microsomal activation of fluoranthene to mutagenic metabolites.

John R. Babson; Sandra Russo-Rodriguez; Ruth V. Wattley; Paul L. Bergstein; William H. Rastetter; Howard L. Liber; Barbara M. Andon; William G. Thilly; Gerald N. Wogan

The in vitro metabolism of fluoranthene (FA) was assessed by incubating 3-[3H]FA, the synthesis of which is described, with rat hepatic microsomal enzymes. Several metabolites including the FA 2,3-diol, FA 2-3,-quinone, 3-OH-FA, 1-OH-FA, and 8-OH-FA were isolated by high-pressure liquid chromatography and identified by comparison of chromatographic properties and uv-visible spectra with those of synthetic standards. The major metabolite produced over the FA concentration range studied (23-233 microM) was FA 2,3-diol, accounting for 29-43% of the total extractable metabolites. This diol was characterized further by high-resolution mass spectroscopy and H-NMR and determined to be identical in structure to the trans-2,3-dihydroxy-2,3-dihydrofluoranthene. The FA 2,3-diol, syn and anti 2,3-diol-1,10b-epoxides, FA 2,3-quinone, and FA 7,8-diol were all shown to be mutagenic toward Salmonella typhimurium TM677. The FA 1,10b-diol and syn and anti FA 1,10b-diol-2,3-epoxides were not mutagenic. The epoxide hydrolase inhibitor, 3,3,3-trichloropropylene oxide, markedly reduced the mutagenic potency of FA while concurrently inhibiting FA 2,3-diol production but not overall FA metabolism. These results suggests that a major metabolic activation pathway of FA resulting in the production of mutagenic species involves the formation of the FA 2,3-diol and the subsequent oxidation of this diol to a FA 2,3-diol-1,10b-epoxide. Another minor activation pathway with mutagenic endpoints may involve the formation of the 7,8-diol.


Tetrahedron Letters | 1982

Sirodesmin A: Synthesis of a chiral left half.

William H. Rastetter; J. Adams; Jon Bordner

Abstract A stereoselective and chiral synthesis of a precursor to the fungal metabolite sirodesin A ( 1 ) is described. The correct relative and absolute confirugation for intermediate 3 (Scheme 1) is established in a single, highly enantioselective epoxidation.


Tetrahedron Letters | 1982

Hydration of the 2-monoanil of 1,3-diphenylpropane-1,2,3-trione. Revised structure of the hydration product.

Jeremiah P. Freeman; Makhluf J. Haddadin; William H. Rastetter; T. Chancellor

Abstract The base-catalyzed hydration of anil 1 affords O-benzoylmandelanilide ( 7 ) rather than hydroxylamine 2 as was previously reported.


Tetrahedron Letters | 1979

Oxaziridines and oxygen transfer. A revised mechanism for the kinetic resolution of 2-n-propyl-3-methyl-3-iso-butyloxaziridine by brucine.

William H. Rastetter; John W. Frost

Abstract The mechanism of kinetic resolution of an oxaziridine by brucine is re-examined. Contrary to a currently accepted report, two oxaziridines re-investigated do not transfer oxygen to the tertiary amine, brucine.


Tetrahedron Letters | 1979

On the biogenesis of gliotoxin. Synthesis of 3-(β-aminoethyl)benzene oxide.

William H. Rastetter; Larry J. Nummy

Abstract The synthesis of 3-(β-aminoethyl)benzene oxide ( 7 is described. The failure of 7 to ring close ( 7 → 8 ) is attributed to the low “nucleophilic susceptibility” of the arene oxide.


Tetrahedron Letters | 1979

A crown ether, template-driven, macrolide closure

William H. Rastetter; Dennis P. Phillion

Abstract Macrolide formation from reactive crown ether 1 is driven by the proximate binding of alkoxide and thioester functionalities.


Journal of Organic Chemistry | 1981

Synthesis of iron chelators. Enterobactin, enantioenterobactin, and a chiral analog

William H. Rastetter; Thomas J. Erickson; Michael C. Venuti


Carcinogenesis | 1986

In vitro DNA-binding of microsomally-activated fluoranthene: evidence that the major product is a fluoranthene N2-deoxyguanosine adduct

John R. Babson; Sandra Russo-Rodriguez; William H. Rastetter; Gerald N. Wogan


Journal of Organic Chemistry | 1982

Fluoranthene: synthesis and mutagenicity of four diol epoxides

William H. Rastetter; Robert B. Nachbar; Sandra Russo-Rodriguez; Ruth V. Wattley; William G. Thilly; Barbara M. Andon; William L. Jorgensen; Mustafa Ibrahim


Journal of the American Chemical Society | 1975

sym-oxepin oxide.

William H. Rastetter

Collaboration


Dive into the William H. Rastetter's collaboration.

Top Co-Authors

Avatar

Thomas J. Richard

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

John W. Frost

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dennis P. Phillion

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

J. Adams

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Larry J. Nummy

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Sandra Russo-Rodriguez

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Barbara M. Andon

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar

Gerald N. Wogan

Massachusetts Institute of Technology

View shared research outputs
Researchain Logo
Decentralizing Knowledge